tetano
Editor, Senior Moderator
J Clin Microbiol
. 2020 Jul 20;JCM.01598-20.
doi: 10.1128/JCM.01598-20. Online ahead of print.
A recurrent mutation at position 26,340 of SARS-CoV-2 is associated with failure of the E-gene qRT-PCR utilized in a commercial dual-target diagnostic assay
Maria Artesi[SUP] 1 [/SUP], S?bastien Bontems[SUP] 2 [/SUP], Paul G?bbels[SUP] 3 [/SUP], Marc Franckh[SUP] 3 [/SUP], Piet Maes[SUP] 4 [/SUP], Rapha?l Boreux[SUP] 2 [/SUP], C?cile Meex[SUP] 2 [/SUP], Pierrette Melin[SUP] 2 [/SUP], Marie-Pierre Hayette[SUP] 5 [/SUP], Vincent Bours[SUP] 6 7 [/SUP], Keith Durkin[SUP] 6 [/SUP]
Affiliations
Abstract
Control of the ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic requires accurate laboratory testing to identify infected individuals, while also clearing essential staff to continue work. At the current time a number of qRT-PCR assays have been developed to identify SARS-CoV-2, targeting multiple positions in the viral genome. While the mutation rate of SARS-CoV-2 is moderate, given the large number of transmission chains it is prudent to monitor circulating viruses for variants that might compromise these assays. Here we report the identification of a C-to-U transition at position 26,340 of the SARS-CoV-2 genome which is associated with failure of the cobas? SARS-CoV-2 E-gene qRT-PCR in eight patients. As the cobas? SARS-CoV-2 assay targets two positions in the genome, the individuals carrying this variant were still called as SARS-CoV-2 positive. Whole genome sequencing of SARS-CoV-2 showed all to carry closely related viruses. Examination of viral genomes deposited on GISAID showed this mutation has arisen independently at least four times. This work highlights the necessity of monitoring SARS-CoV-2 for the emergence of SNPs which might adversely affect RT-PCRs used in diagnostics. Additionally, it argues that two regions in SARS-CoV-2 should be targeted to avoid false negatives.
. 2020 Jul 20;JCM.01598-20.
doi: 10.1128/JCM.01598-20. Online ahead of print.
A recurrent mutation at position 26,340 of SARS-CoV-2 is associated with failure of the E-gene qRT-PCR utilized in a commercial dual-target diagnostic assay
Maria Artesi[SUP] 1 [/SUP], S?bastien Bontems[SUP] 2 [/SUP], Paul G?bbels[SUP] 3 [/SUP], Marc Franckh[SUP] 3 [/SUP], Piet Maes[SUP] 4 [/SUP], Rapha?l Boreux[SUP] 2 [/SUP], C?cile Meex[SUP] 2 [/SUP], Pierrette Melin[SUP] 2 [/SUP], Marie-Pierre Hayette[SUP] 5 [/SUP], Vincent Bours[SUP] 6 7 [/SUP], Keith Durkin[SUP] 6 [/SUP]
Affiliations
- PMID: 32690547
- DOI: 10.1128/JCM.01598-20
Abstract
Control of the ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic requires accurate laboratory testing to identify infected individuals, while also clearing essential staff to continue work. At the current time a number of qRT-PCR assays have been developed to identify SARS-CoV-2, targeting multiple positions in the viral genome. While the mutation rate of SARS-CoV-2 is moderate, given the large number of transmission chains it is prudent to monitor circulating viruses for variants that might compromise these assays. Here we report the identification of a C-to-U transition at position 26,340 of the SARS-CoV-2 genome which is associated with failure of the cobas? SARS-CoV-2 E-gene qRT-PCR in eight patients. As the cobas? SARS-CoV-2 assay targets two positions in the genome, the individuals carrying this variant were still called as SARS-CoV-2 positive. Whole genome sequencing of SARS-CoV-2 showed all to carry closely related viruses. Examination of viral genomes deposited on GISAID showed this mutation has arisen independently at least four times. This work highlights the necessity of monitoring SARS-CoV-2 for the emergence of SNPs which might adversely affect RT-PCRs used in diagnostics. Additionally, it argues that two regions in SARS-CoV-2 should be targeted to avoid false negatives.